Recordati Strikes Major Deal with Amarin for Vazkepa® Commercialization
Deal News | Jun 26, 2025 | Hogan Lovells
Recordati has entered into licensing and supply agreements with Amarin to commercialize Vazkepa®. The deal involves an initial payment of US$25 million from Recordati to Amarin and commercial milestones that could total as much as an additional US$150 million. The agreements stipulate that Amarin will supply the finished product to Recordati and receive royalties. Hogan Lovells advised Recordati, with a multi-jurisdictional team led by partners Francesco Stella and Penny Powell. The team also involved members from Hogan Lovells offices across Europe and the United States. Recordati's in-house legal team, headed by Chief Legal Officer Bibianne Bon, closely collaborated with Hogan Lovells.
Sectors
- Pharmaceuticals
- Legal Services
Geography
- United States – Amarin, one of the companies involved, is based in the United States.
- Italy – Recordati, the other primary company in the agreements, is based in Italy.
- Europe – Hogan Lovells' offices in various European countries, including the UK, Italy, Spain, France, Ireland, the Netherlands, Austria, Portugal, Sweden, and Switzerland, were involved in advising on the transaction.
Industry
- Pharmaceuticals – The article involves the commercialization of Vazkepa®, a pharmaceutical product, and the companies involved operate within the pharmaceutical industry.
- Legal Services – Hogan Lovells, a law firm, provided legal advice and services for the agreements, making this relevant to the legal services sector.
Financials
- US$25 million – The upfront fee Recordati will pay Amarin in the licensing and supply agreements.
- US$150 million – The potential total amount of commercial milestones if the agreed-upon targets are reached.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Recordati | Buyer | Company | An Italian pharmaceutical company involved in the commercialization of Vazkepa® through the agreement. |
| Amarin | Vendor | Company | A biopharmaceutical company based in the United States, entering a licensing and supply agreement with Recordati. |
| Hogan Lovells | Legal Advisor | Company | A multinational law firm advising Recordati on the agreements. |